Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Terrestrial Bio, Inc.

Terrestrial Bio, Inc.

Stage unknownWoburn, MABiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
4
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
4 rounds
  1. Mar 4, 2026
    Form D equity offering · $57.3M (form d sold) · 16 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Terrestrial Bio, Inc. filed Form D: $57,301,758 sold of $83,538,199, Biotechnology”
  2. Aug 27, 2025
    Form D equity offering · $7.9M (form d sold) · 4 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Vaxess Technologies, Inc. filed Form D: $7,903,411 sold of $10,000,000, Biotechnology”
  3. Feb 14, 2025
    Form D equity offering · $8.4M (form d sold) · 3 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Vaxess Technologies, Inc. filed Form D: $8,400,000 sold of $10,000,000, Biotechnology”
  4. May 13, 2024
    Form D equity offering · $10.8M (form d sold) · 6 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Vaxess Technologies, Inc. filed Form D: $10,775,983 sold of $12,000,000, Biotechnology”
Investors on record
3 edges
People
11 officers, 4 directors
Timeline
4
  1. Mar 19, 2026
    Terrestrial Bio, Inc. filed Form D: $57,301,758 sold of $83,538,199, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Sep 10, 2025
    Vaxess Technologies, Inc. filed Form D: $7,903,411 sold of $10,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  3. Feb 26, 2025
    Vaxess Technologies, Inc. filed Form D: $8,400,000 sold of $10,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  4. May 28, 2024
    Vaxess Technologies, Inc. filed Form D: $10,775,983 sold of $12,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
60 observations
Every observation on this company